Flannery, Jessica E.
Hinshaw, Stephen P.
Kollins, Scott H.
Stamatis, Caitlin A.
Article History
Received: 8 January 2024
Accepted: 15 April 2024
First Online: 29 April 2024
Declarations
:
: All trials were conducted in compliance with the Institutional Review Board (IRB) regulations stated in Title 21 of the US Code of Federal Regulations (CFR), Part 56, Good Clinical Practice (GCP) regulations and guidelines, and all applicable local regulations. The trials were approved by each site’s institutional review board (WIRB-Copernicus Group). Written informed consent or assent was obtained from all participants, consent from parents or legally authorized representatives and assent for children and adolescents, respectively, and as appropriate given the participants' ages. IRB-approved forms containing a detailed description of the study treatment, study procedures, and risks were provided to participants and caregivers.
: Not applicable: manuscript does not contains any individual person’s data in any form.
: Akili Interactive Labs provided research support for this study and played a role in the conceptualization and design of the trial, the decision to publish, and the preparation of the manuscript. In addition, the authors declare the following employment and financial interests: J.E.F., S.H.K., C.A.S. are employees at Akili Interactive and own stock or equity. The views and opinions expressed within this manuscript are those of the authors and do not necessarily represent those of the sponsor.